PBYI Crosses Above Average Analyst Target
August 24, 2016 at 07:38 AM EDT
In recent trading, shares of Puma Biotechnology, Inc. (PBYI) have crossed above the average analyst 12-month target price of $55.33, changing hands for $56.62/share..
